Skip to main content

Table 4 Comparison of characteristics of PDSS in routine clinical practice and formal clinical trials [5-8]

From: Olanzapine long-acting injection: a review of first experiences of post-injection delirium/sedation syndrome in routine clinical practice

Characteristic

Routine clinical practice

Formal clinical trials

Rate of PDSS (% of injections)

0.07%

0.07–0.09%

Rate of PDSS (% of patients)

0.46–1.03%

1.4–2.0%

Cases starting within 60 minutes of injection

91%

80%

Cases requiring hospitalisation

65%

77%

Cases requiring medication/specific treatment

31%

37%

Cases showing recovery within 72 hours

88%

100%

Cases involving delirium-related AEs

86%

97%

Cases involving sedation-related AEs

89%

87%

Cases involving delirium & sedation-related AEs

74%

83%

  1. AE = adverse event; PDSS = post-injection delirium/sedation syndrome.